Top Story

Sugary drinks tied to 184,000 deaths annually worldwide

Sugary drinks tied to 184,000 deaths annually worldwide
July 1, 2015

Sugar-sweetened beverages contribute to 184,000 deaths per year worldwide, primarily from diabetes and cardiovascular disease, according to research in Circulation.

In an analysis of national surveys and food availability data and a meta-analysis of pooled cohort studies and disease-specific mortality data from around the world, researchers also found that the consumption rate of sugary drinks varied greatly from country to country and between sexes and age ranges, with young adult males from Latin America and the Caribbean consuming the most and at greatest risk for disease and death.

In the Journals

RIBS IV: EES superior to DEB for DES in-stent restenosis

July 1, 2015
Everolimus-eluting stents yielded superior long-term outcomes compared with drug-eluting balloons for the treatment of patients with drug-eluting stent in-stent…
Perspective

IOM report calls for national cardiac arrest registry, more CPR training

July 1, 2015
The Institute of Medicine released a report recommending several actions to improve survival rates and quality of life after cardiac arrest, including establishing a…
Blog

BLOG: Health care providers need to consider options offered by patient financing programs

July 1, 2015
Most health care practices have financial policies in place that require payment by cash, check or major credit card for out-of-pocket costs. However, in today’s…
Meeting News Coverage

Rivaroxaban shows continued safety data in nonvalvular AF, consistent with phase 3 trials

July 1, 2015
Data from an ongoing study evaluating the safety of rivaroxaban in patients with nonvalvular atrial fibrillation showed rates of major bleeding and fatalities similar to…
More News Headlines »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Oral Antiplatelet Therapy in a Patient with Acute Coronary Syndrome and Percutaneous Coronary Intervention

Case Study: Oral Antiplatelet Therapy in a Patient with ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, over 780,000 persons annually will experience an acute coronary syndrome…
More »
morganatic-roan